Health Care Digest: UCSF’s ImmunoX revolution, Gilead’s deal, a pain breakthrough and more


Editor's note: The San Francisco Business Times is launching this weekly health care digest by biotech reporter Ron Leuty. It features a round-up of local news items, musings from notable figures, insights from other publications and must-reads from our own newsroom. As always, I'd love to hear what you think and how we can improve. Please email biotech reporter Ron Leuty ([email protected]) with any feedback, suggestions or possible news items for this feature.

A gift from Gerson Bakar…

Previous Central Eastside's next office building will bring something new to the area — a parking garage
Next Hawaii banks initiate financial assistance for those impacted by Tropical Storm Olivia